These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17641993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
    Filson S.
    IDrugs; 2007 Jun; 10(6):359-61. PubMed ID: 17641994
    [No Abstract] [Full Text] [Related]

  • 3. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
    Mitra AP.
    IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
    [No Abstract] [Full Text] [Related]

  • 4. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part III.
    Sovran L.
    IDrugs; 2007 Jun; 10(6):362-5. PubMed ID: 17641995
    [No Abstract] [Full Text] [Related]

  • 5. American Association for Cancer Research 98th Annual Meeting. Angiogenesis and anti-angiogenesis in cancer.
    Duda DG.
    IDrugs; 2007 Jun; 10(6):366-9. PubMed ID: 17641996
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Microtubules: a dynamic target in cancer therapy.
    Pasquier E, Kavallaris M.
    IUBMB Life; 2008 Mar; 60(3):165-70. PubMed ID: 18380008
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The epothilones: how pharmacology relates to clinical utility.
    Michaud LB.
    Ann Pharmacother; 2009 Jul; 43(7):1294-309. PubMed ID: 19584389
    [Abstract] [Full Text] [Related]

  • 13. American Society of Clinical Oncology--44th Annual Meeting. Target identification and data from preclinical and clinical studies.
    Kibble A.
    IDrugs; 2008 Aug; 11(8):541-4. PubMed ID: 18683082
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental models for the development of new medical treatments in prostate cancer.
    Chauchereau A.
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S200-14. PubMed ID: 21943976
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New sources and new antitumor drugs in development.
    Weiss RB.
    Semin Oncol; 1997 Apr; 24(2):153-5. PubMed ID: 9129685
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.